Cargando…

Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma

SIMPLE SUMMARY: Significant gender disparities have been highlighted in the incidence, aggressiveness, and prognosis of HCC. A different epidemiological distribution of the risk factors of liver damage and, above all, the actions of sex hormones are at the basis of these differences. Accurate knowle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nevola, Riccardo, Tortorella, Giovanni, Rosato, Valerio, Rinaldi, Luca, Imbriani, Simona, Perillo, Pasquale, Mastrocinque, Davide, La Montagna, Marco, Russo, Antonio, Di Lorenzo, Giovanni, Alfano, Maria, Rocco, Maria, Ricozzi, Carmen, Gjeloshi, Klodian, Sasso, Ferdinando Carlo, Marfella, Raffaele, Marrone, Aldo, Kondili, Loreta Anesti, Esposito, Nicolino, Claar, Ernesto, Cozzolino, Domenico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376683/ https://www.ncbi.nlm.nih.gov/pubmed/37508414 http://dx.doi.org/10.3390/biology12070984

Ejemplares similares

Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era?
por: Nevola, Riccardo, et al.
Publicado: (2023)

Elimination of Hepatitis C in Southern Italy: A Model of HCV Screening and Linkage to Care among Hospitalized Patients at Different Hospital Divisions
por: Rosato, Valerio, et al.
Publicado: (2022)

HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis
por: Nevola, Riccardo, et al.
Publicado: (2023)

GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives
por: Nevola, Riccardo, et al.
Publicado: (2023)

Predictors of early and late hepatocellular carcinoma recurrence
por: Nevola, Riccardo, et al.
Publicado: (2023)

Platypnea-orthodeoxia syndrome in SARS-CoV-2 related ARDS: a case report
por: Aprea, Concetta, et al.
Publicado: (2022)

Can Telemedicine Optimize the HCV Care Cascade in People Who Use Drugs? Features of an Innovative Decentralization Model and Comparison with Other Micro-Elimination Strategies
por: Nevola, Riccardo, et al.
Publicado: (2022)

Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination
por: Nevola, Riccardo, et al.
Publicado: (2023)

Telemedicine Improves HCV Elimination among Italian People Who Use Drugs: An Innovative Therapeutic Model to Increase the Adherence to Treatment into Addiction Care Centers Evaluated before and during the COVID-19 Pandemic
por: Rosato, Valerio, et al.
Publicado: (2022)

Incretin Hormones: The Link between Glycemic Index and Cardiometabolic Diseases
por: Salvatore, Teresa, et al.
Publicado: (2019)

Unusual liver‐related heart injury
por: Nevola, Riccardo, et al.
Publicado: (2020)

Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options
por: Salvatore, Teresa, et al.
Publicado: (2022)

Metformin: A Potential Therapeutic Tool for Rheumatologists
por: Salvatore, Teresa, et al.
Publicado: (2020)

Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome
por: Cozzolino, Domenico, et al.
Publicado: (2023)

Non-invasive respiratory support in SARS-CoV-2 related acute respiratory distress syndrome: when is it most appropriate to start treatment?
por: Nevola, Riccardo, et al.
Publicado: (2022)

Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies
por: Vetrano, Erica, et al.
Publicado: (2023)

Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects?
por: Salvatore, Teresa, et al.
Publicado: (2020)

Role of Tight Glycemic Control during Acute Coronary Syndrome on CV Outcome in Type 2 Diabetes
por: Sasso, Ferdinando Carlo, et al.
Publicado: (2018)

Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct‐acting antivirals
por: Nevola, Riccardo, et al.
Publicado: (2020)

Mortality and risk factors of vaccinated and unvaccinated frail patients with COVID-19 treated with anti-SARS-CoV-2 monoclonal antibodies: A real-world study
por: Nevola, Riccardo, et al.
Publicado: (2023)

Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options
por: Galiero, Raffaele, et al.
Publicado: (2023)

Rheumatic disease management in the Campania region of Italy during the COVID-19 pandemic
por: Masini, Francesco, et al.
Publicado: (2020)

Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of Epigenetics
por: Rinaldi, Luca, et al.
Publicado: (2020)

The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial
por: Sasso, Ferdinando Carlo, et al.
Publicado: (2022)

COVID-19 and arrhythmia: The factors associated and the role of myocardial electrical impulse propagation. An observational study based on cardiac telemetric monitoring
por: Cozzolino, Domenico, et al.
Publicado: (2022)

Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease
por: Sasso, Ferdinando Carlo, et al.
Publicado: (2021)

Directly Acting Antiviral-Based Treatment for HCV-Infected Persons Who Inject Drugs: A Multicenter Real-Life Study
por: Messina, Vincenzo, et al.
Publicado: (2020)

Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study
por: Caturano, Alfredo, et al.
Publicado: (2023)

Epidemiology of HCV and HBV in a High Endemic Area of Southern Italy: Opportunities from the COVID-19 Pandemic—Standardized National Screening or One Tailored to Local Epidemiology?
por: Nevola, Riccardo, et al.
Publicado: (2022)

Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19
por: Messina, Vincenzo, et al.
Publicado: (2022)

Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations
por: Galiero, Raffaele, et al.
Publicado: (2023)

Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes
por: Salvatore, Teresa, et al.
Publicado: (2022)

An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors
por: Salvatore, Teresa, et al.
Publicado: (2022)

The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy
por: Galiero, Raffaele, et al.
Publicado: (2020)

Prediction of SARS-CoV-2-Related Lung Inflammation Spreading by V:ERITAS (Vanvitelli Early Recognition of Inflamed Thoracic Areas Spreading)
por: Romano, Ciro, et al.
Publicado: (2022)

Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function
por: Salvatore, Teresa, et al.
Publicado: (2021)

Liver Involvement during SARS-CoV-2 Infection Is Associated with a Worse Respiratory Outcome in COVID-19 Patients
por: Romano, Ciro, et al.
Publicado: (2023)

Will the COVID-19 pandemic affect HCV disease burden?
por: Kondili, Loreta A., et al.
Publicado: (2020)

Economic Consequences of Anti-HCV Treatment of Patients Diagnosed Through Screening in Italy: A Prospective Modelling Analysis
por: Marcellusi, Andrea, et al.
Publicado: (2021)

Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study
por: Galiero, Raffaele, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tdo3g0om4fbiq6hpahsg5kl06e